PTC Therapeutics, Inc.’s Post

Becker Education and Engagement Day is this Saturday! If you were not able to attend last year's BEED, it's not too late to gain valuable insights from Dr. Vandenborne's 2023 presentation: "Imaging Muscles in Becker Muscular Dystrophy." Learn more about how measuring muscle fat fraction helps inform clinical trials: https://lnkd.in/eRGVxswg #BeckerMuscularDystrophy

AMD: The first six months of vision impairment. A unique approach After retiring from a 40-year career in Low Vision rehabilitation, I unexpectedly met patients in Prescott, Arizona, where I donated my time. Instead of traditional methods, I opted for a unique approach - simply talking and listening during two-hour sessions. Having interacted with over 100 patients this last year, I identified common topics shared by everyone. Drawing from my 50 years of experience living with Stargardt macular dystrophy, I provide easily understandable explanations. While I continue to gain insights, I aim to publish the top 15 topics that encapsulate what patients need to know - from symptoms to solutions. Stay connected via email at [email protected].

📖 Did you know it's National Reading Month? Here at Kessler Foundation, Olga Boukrina, PhD, senior research scientist in the Center for Stroke Rehabilitation Research, is helping #stroke survivors recover their ability to read and process language. Listen here: https://lnkd.in/e4Tf7k8U [Video Description: A background with shades of blue, hexagonal shapes and an exoskeleton. There is large white text that reads "Fast Takes" with a green underline beneath it. In small, white writing it reads "Research that Changes Lives. Episode 13."]

In honor of #ArabAmericanHeritageMonth, the NeuroLeadership Institute's DEI Center of Excellence celebrates luminaries in science who are planting the seeds for a better future — by making history today. Today, we honor the Michigan Center for Contextual Factors in Alzheimer's Disease (MCCFAD). Watch the video below to learn about their work.

🚨 The Neuro Science Monitor Special Edition: Countdown to NCS 2024 ‼️ We're just 5 days away from the biggest neurocritical care event of the year – the 22nd Annual Meeting of the Neurocritical Care Society (NCS) in sunny San Diego, California! ☀️ We're so excited to connect with neurocritical care professionals from around the world and discuss the future of brain injury care. 📰✨ In this special edition of our newsletter, we're spotlighting our booth (#318) at the event; stop by to explore the Moberg AI Ecosystem, see live demos of our software, learn how we may help your work, check out some of our free resources surrounding AI and neurocritical care, and more. (Plus, for our current partners and collaborators, swing by for a special gift). Whether you're a current collaborator, a new connection, or just curious about neuromonitoring, we'd love to see you there! 💙 📬 Read more in this month's Neuro Science Monitor: https://lnkd.in/eJGPb3Zk #NCS2024 #NeurocriticalCare #MultimodalMonitoring #TheNeuroScienceMonitor #BrainInjuryCare

End of the EU-funded MeDiTATe project we have been working on in the last few years.

🩺 Unraveling the Secrets of Cardiac Regeneration! 💪 We're diving into the heart of the matter, exploring the mechanisms behind cardiac healing. Follow us as we uncover valuable insights in our quest to reshape cardiac care. #CardiacRegeneration #Research #REBORNProject

🧠 Exploring New Frontiers in Alzheimer's Research 🧠 We're excited to share this insightful Medicine Grand Rounds presentation featuring Huntington Potter and Brice McConnell from the CU Alzheimer's and Cognition Center. They discuss Sargramostim/GM-CSF as a potential treatment for Alzheimer's disease, highlighting research from preclinical trials to ongoing Phase II clinical trials. This research could pave the way for new therapies in the fight against Alzheimer’s. A must-watch for anyone interested in neurodegenerative diseases! #AlzheimersResearch #Neurology #ClinicalTrials #CUAnschutz 🎥 Watch the full presentation here:

Your Gut-Brain Connection: Parkison's edition Parkinson's Disease is a brain disorder where the cells that produce a neurotransmitter that calms muscle movements are dying off. This leads to the characteristic tremors in the hands and difficulty walking. These patients are at a much greater risk of falls and pneumonia-related deaths. Muhammed Ali and Michael J. Fox are probably the most commonly known people who have been diagnosed with PD, but some 60,000 people in the US alone are diagnosed each year. Luckily, just like Alzheimer's, there are a lot of things you can control to lower (and increase) your risk. These can include: *Coffee 40% lower *Smoking 30% lower (not suggesting you take up smoking....) *Physical activity 20% lower *Family history of PD 320% higher *Dyspepsia 80% higher *Exposure to pesticides 230% higher *Oils 560% higher *Metals 280% higher *General anesthesia 610% higher Notice the "dyspepsia" risk factor? This has been found in multiple studies over the years, and this one is no exception. In it, researchers followed 9,350 patients (average age 52) for 15 years who had an upper endoscopy scope done. Specifically, they looked for people who had damage to the lining of the esophagus, stomach or small intestings (specifically, erosions, inflammation of the esophagus, ulcers and stomach injury). 15 years later, those patients who had the damage were 415% more likely to be diagnosed with Parkinson's Disease (2.2% vs 0.5%). Find out the specifics in the video. https://lnkd.in/gVAX4MkX